| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/23/2000 | US6066781 Chimeric nucleotide sequences for use in producing proteins other than amylase |
| 05/23/2000 | US6066778 Rodent genetically engineered to be defective in blood coagulation; models for evaluating potentially useful anticoagulant agents |
| 05/23/2000 | US6066726 Neuron-specific transcriptional promoter |
| 05/23/2000 | US6066725 Production of recombinant polypeptides by bovine species and transgenic methods |
| 05/23/2000 | US6066724 Human endometrial specific steroid-binding factor I, II and III |
| 05/23/2000 | US6066723 Nucleotide sequence coding kinase modulator and cancer marker polypeptide; for the screening of biopsy tissue for detection of cancer; for the diagnosis and treatment of cancer |
| 05/23/2000 | US6066717 RsbW-1 protein |
| 05/23/2000 | US6066716 Purified heat shock protein complexes |
| 05/23/2000 | US6066624 Gene therapy for solid tumors using adenoviral vectors comprising suicide genes and cytokine genes |
| 05/23/2000 | US6066623 Polynucleotide vaccine protective against malaria, methods of protection and vector for delivering polynucleotide vaccines |
| 05/23/2000 | US6066622 Immunomodulating peptides and methods of use |
| 05/23/2000 | US6066621 Response inhibiting peptide |
| 05/23/2000 | US6066619 Non-aqueous protic peptide formulations |
| 05/23/2000 | US6066618 Regulation of cell proliferation and differentiation using peptides |
| 05/23/2000 | US6066617 Polypeptide |
| 05/23/2000 | US6066616 Administering octreotide |
| 05/23/2000 | US6066503 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 05/23/2000 | US6066502 Endothelin converting enzyme (ECE) |
| 05/23/2000 | US6066498 Compositions for the treatment and diagnosis of immune disorders |
| 05/23/2000 | US6066488 Cathepsin C homolog |
| 05/23/2000 | US6066476 Modified green fluorescent proteins |
| 05/23/2000 | US6066475 Parathyroid cytosolic autoantigens recognized by autoantibodies from patients with acquired hypoparathyroidism |
| 05/23/2000 | US6066474 Y2H56 A strong IKK binding protein |
| 05/23/2000 | US6066471 Proteinase inhibitor for food processing |
| 05/23/2000 | US6066469 Cloning, expression, and uses of human lactoferrin |
| 05/23/2000 | US6066463 Method and compositions for treatment of BCR-ABL associated leukemias and other cell proliferative disorders |
| 05/23/2000 | US6066451 Neural cell protein marker RR/B and DNA encoding the same |
| 05/23/2000 | US6066324 Carboxyl terminal of papilloma virus L1 region is not required for formation of virus-like particles |
| 05/23/2000 | US6066322 Administering antibody to treat asthma; treating helper t-cell mediated conditions |
| 05/23/2000 | US6066321 Diagnosing inflammation and autoimmune diseases |
| 05/23/2000 | US6066320 Isolating antiserum with nerve cells presenting anti-prion protein |
| 05/23/2000 | US6066318 Multi-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factors |
| 05/23/2000 | US6066317 Method of using IL-11 for treating deficiencies in hematopoietic progenitor or stem cells |
| 05/23/2000 | CA2167630C Cdna of dock180 gene and dock180 protein |
| 05/23/2000 | CA2165162C Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| 05/23/2000 | CA2072125C Design and construction of non-infectious human retroviral mutants deficient in genomic rna |
| 05/23/2000 | CA2066998C Recombinant varicella-zoster virus and process for constructing same |
| 05/23/2000 | CA2066997C Antimicrobial peptide and antimicrobial agent |
| 05/23/2000 | CA2062732C A mutated subtilisin protease |
| 05/23/2000 | CA2006818C Insulin derivatives, a process for the preparation thereof, the use thereof and a pharmaceutical formulation containing them |
| 05/23/2000 | CA2002318C Dna encoding ¬lys46,asp97,asp113|and¬lys46,asp97,asp137|thaumatin i polypeptides |
| 05/23/2000 | CA1340999C Nuclear factors associated with transcriptional regulation |
| 05/23/2000 | CA1340998C Dnas and processes for their preparation, novel plasmids possessing them, novel polypeptides and processes for their preparation and novel anti-tumor agents comprising said polypeptides |
| 05/20/2000 | CA2252064A1 Aquatic nitrite oxidising microorganisms |
| 05/19/2000 | CA2254444A1 Cell line for producing repressor proteins |
| 05/18/2000 | WO2000028323A1 Methods for identifying modulators of bs69 activity |
| 05/18/2000 | WO2000028083A1 Mouse 7-transmembrane receptor gpr43 |
| 05/18/2000 | WO2000028079A2 Genetic variation associated with aplastic anemia, and diagnosis and therapy based thereon |
| 05/18/2000 | WO2000028075A1 Bacillus strain and assay methods |
| 05/18/2000 | WO2000028072A1 Biomarkers for oxidative stress |
| 05/18/2000 | WO2000028067A1 Enzymatic amidation of peptides |
| 05/18/2000 | WO2000028066A1 Host cells expressing recombinant human erythropoietin |
| 05/18/2000 | WO2000028065A1 Method for the production of fvii |
| 05/18/2000 | WO2000028061A2 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 05/18/2000 | WO2000028060A2 Cells for the production of helper dependent adenoviral vectors |
| 05/18/2000 | WO2000028058A2 Transcriptional activator lec1 nucleic acids, polypeptides and their uses |
| 05/18/2000 | WO2000028056A2 HYPERSENSITIVE RESPONSE ELICITOR FROM $i(AGROBACTERIUM VITIS) |
| 05/18/2000 | WO2000028055A2 Hypersensitive response elicitor-induced stress resistance |
| 05/18/2000 | WO2000028054A2 Plant proteins that interact with nuclear matrix proteins and function as transcriptional activators |
| 05/18/2000 | WO2000028052A2 Nucleic acid molecules from rice encoding an r1 protein and their use for the production of modified starch |
| 05/18/2000 | WO2000028051A1 Method to control gene expression in bacteria, namely rhizobiaceae, to improve root nodule development, nitrogen fixation and plant biomass production |
| 05/18/2000 | WO2000028041A1 Delivery of superoxide dismutase to neuronal cells |
| 05/18/2000 | WO2000028040A2 Cloning of rhadinovirus genome and methods for its use |
| 05/18/2000 | WO2000028039A2 Identification of senv genotypes |
| 05/18/2000 | WO2000028038A2 Virulence genes and proteins, and their use |
| 05/18/2000 | WO2000028037A1 CATFIIIA CANDIDA ALBICANS tfIIIA GENE (CatfIIIA) AND THE CODED CATFIIIA PROTEIN |
| 05/18/2000 | WO2000028036A2 Disease resistance factors |
| 05/18/2000 | WO2000028035A1 CHEMOKINE β-7 |
| 05/18/2000 | WO2000028034A2 Cytokine signal regulators |
| 05/18/2000 | WO2000028033A2 Nucleic acids and polypeptides having altered expression in the t84 gut barrier model |
| 05/18/2000 | WO2000028032A2 Human cell surface receptor proteins |
| 05/18/2000 | WO2000028030A1 Human secretory protein-61 |
| 05/18/2000 | WO2000028029A2 Cell surface glycoproteins |
| 05/18/2000 | WO2000028028A1 G-protein coupled receptors, homologous to ebv-induced gpcr 2 (ebi-2). methods to seek for ligands thereof |
| 05/18/2000 | WO2000028027A2 Corticosteroid synthesis-associated genes |
| 05/18/2000 | WO2000028026A2 Gene expression modulated by opiate administration and withdrawal |
| 05/18/2000 | WO2000028025A1 Pholasin |
| 05/18/2000 | WO2000028024A1 htfIIIA HUMAN GENE AND CODED hTFIIIA PROTEIN |
| 05/18/2000 | WO2000028023A2 Ischaemia/reperfusion-inducible dna's and proteins |
| 05/18/2000 | WO2000028021A1 A factor viii-polypeptide with factor viii:c-activity |
| 05/18/2000 | WO2000028020A2 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor |
| 05/18/2000 | WO2000028013A2 Gene expression modulated by activation of microglia or macrophages |
| 05/18/2000 | WO2000028011A2 Fk506-based regulation of biological events |
| 05/18/2000 | WO2000028009A1 Biological compositions, components thereof and uses therefor |
| 05/18/2000 | WO2000028004A1 Virus vectors and methods of making and administering the same |
| 05/18/2000 | WO2000028003A1 Avipox vector coding an hiv antigen and a cytokine |
| 05/18/2000 | WO2000028002A1 Dna molecules encoding the melanocortin 5 receptor protein from rhesus monkey |
| 05/18/2000 | WO2000028001A1 Modified exosomes and uses |
| 05/18/2000 | WO2000027997A1 Method for the massive culture of cells producing recombinant human erythropoietin |
| 05/18/2000 | WO2000027994A2 Chlamydia pneumoniae genome sequence |
| 05/18/2000 | WO2000027885A1 Novel chimeric polypeptide |
| 05/18/2000 | WO2000027883A2 A method of treating tumors using fas-induced apoptosis |
| 05/18/2000 | WO2000027882A1 Hnovilr |
| 05/18/2000 | WO2000027881A2 Human interleukin 10 mutant proteins |
| 05/18/2000 | WO2000027880A2 Rantes-derived peptides with anti-hiv activity |
| 05/18/2000 | WO2000027879A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof |
| 05/18/2000 | WO2000027878A1 Screening system for zinc finger polypeptides for a desired binding ability |
| 05/18/2000 | WO2000027877A1 Novel major facilitator superfamily polypeptide, uses thereof and nucleic acids encoding same |
| 05/18/2000 | WO2000027876A1 Method for the isolation of lectins and the obtained purified lectins for use as a medicament |
| 05/18/2000 | WO2000027875A2 Activity dependent neurotrophic factor iii (adnf iii) |